A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT00923182 · COMPLETED
Trial details
- NCT number
- NCT00923182
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-08-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.